جست‌وجوی استاد و پژوهشگر

Ahmad Faroukمشاهده پروفایل

مدرس ارشد

• Cardiothoracic Surgery
• Minimally Invasive Surgery
• Atrial Fibrillation
• +۶ مورد دیگر

Dr. Ahmad Farouk is a Senior Lecturer at the Jeffrey Cheah School of Medicine and Health Sciences, Monash University, Malaysia, where he has been affiliated since January 2007. He is also associated with the Victorian Heart Institute (VHI) and contributes to research and teaching in cardiothoracic surgery and medical education. His academic roles span anatomy, histology, clinical skills, and MBBS program coordination. His research interests focus on minimally invasive surgery , atrial fibrillation , and post-CABG outcomes , with recent publications exploring surgical techniques, wound healing with natural extracts, and the intersection of religion and public health. His research has been presented across Asia and Europe, and he contributes to advancing knowledge in cardiovascular medicine and surgical innovation. His recent publications (2022) reflect a multidisciplinary approach, covering clinical cardiology, surgical outcomes, natural therapeutics, and public health. These works span journals and book chapters in Reviews in Cardiovascular Medicine , Health Promotion International , and Springer publications, indicating strong engagement in both clinical and translational research. Several distinguished medals at National and International levels Dr. Farouk is actively involved in academic mentoring, supervising Bachelor of Medical Sciences (Honors) students, and contributing to curriculum development through roles in the Malaysian Anatomy Teaching & Assessment Working Group (MATAWG). He has participated in externally funded research, including a project on breast cancer signaling pathways (2019–2022). His teaching spans multiple years and disciplines, reflecting a deep commitment to medical education. He is engaged in professional academic service, organizing conferences such as the Malaysian Association of Thoracic & Cardiovascular Surgery Annual Scientific Meeting and the MAEMHS Conference 2023. He also serves on the Examination & Assessment Subcommittee for the UiTM-IJN Cardiothoracic Surgery Postgraduate Programme, contributing to national postgraduate medical education standards.

Joanna Cohenمشاهده پروفایل

استاد

• tobacco control
• public health policy
• tobacco industry
• +۶ مورد دیگر

Joanna Cohen, PhD, MHSc, is the Bloomberg Professor of Disease Prevention and Chair of the Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health . She directs the Institute for Global Tobacco Control and has led tobacco policy research for over 30 years, focusing on tobacco control, public health policy, and policy evaluation. Her work examines tobacco industry strategies, health communication, and behavioral interventions to reduce tobacco use. Education: PhD in Health Policy (University of North Carolina, 1999), MHSc in Community Health (University of Toronto, 1992) Research Trends: Her recent work includes studies on electronic nicotine delivery systems (ENDS), tobacco pricing, warning labels, flavor chemicals, and global policy implementation. Key collaborations span the U.S., Vietnam, Mexico, and Bangladesh. 2025: ENDS dependence, bidi pack perception 2024: Tobacco taxation, PMI funding models 2023: Menthol regulation Scientific Awards: Recipient of multiple teaching and mentoring awards, including the 2004 Robin Badgley Award and 2000 APHA Mentor of the Year. Projects: Leads the Bloomberg Initiative to Reduce Tobacco Use, the VAPER Study, and Tobacco Pack Surveillance System (TPackSS), with a focus on reducing inequalities in tobacco control.

Philip Bakerمشاهده پروفایل

استاد

• Maternal and Fetal Health
• Obstetrics
• Placental Biology
• +۷ مورد دیگر

Philip Baker is a Professor and Pro-Vice-Chancellor for Medicine and Health Sciences at the University of East Anglia, affiliated with Norwich Medical School and the Metabolic Health research group. He previously served as Pro-Vice-Chancellor for Life Sciences and Dean of Medicine at the University of Leicester, demonstrating a strong leadership trajectory in academic medicine. His research focuses on maternal and fetal health, with particular emphasis on placental biology, preeclampsia, prenatal environmental exposures (including air pollution and metals), and neurodevelopmental outcomes. His work integrates clinical obstetrics with molecular and epidemiological approaches, often from an international perspective shaped by leadership roles in North America, Asia, and Australasia. Recent publications highlight ongoing contributions to understanding placental regulation of fetal growth, vasodilatory dysfunction in preeclampsia, and the impact of environmental factors on child development. These works reflect a sustained focus on perinatal medicine and developmental origins of health and disease. Fellow of the Academy of Medical Sciences Principal author of the G8 2010 position paper on 'Health of Women and Children' Baker has supervised over 40 PhD/MD theses and secured over £50 million in direct research funding, with institutional applications exceeding £100 million. His leadership roles have involved managing budgets up to £250 million annually and large research teams. He is actively involved in major research initiatives such as the CLIMB cohort study and the STRIDER trial. He is based at the Bob Champion Research & Education Building at UEA and maintains a high research output, with over 450 peer-reviewed articles and an H-index of approximately 98.

David Todemمشاهده پروفایل

استاد

• Biostatistics
• Epidemiology
• Longitudinal Data Analysis
• +۶ مورد دیگر

David Todem is a Professor in the Department of Epidemiology and Biostatistics at Michigan State University. His work focuses on statistical methodology for longitudinal and clustered data, particularly in applications to cancer research and public health. He holds a Ph.D. in Statistics from the University of Wisconsin-Madison, an M.S. in Biostatistics from Hasselt University (Belgium), and an M.S. in Population Health from the University of Wisconsin-Madison. Dr. Todem's research interests include joint models for time-to-event and longitudinal outcomes, non-identifiable models with informative nonresponse, and testing heterogeneity in mixture models. His applied work addresses critical questions in cancer treatment efficacy, maternal-child health, and chronic disease surveillance. He has developed innovative methods for analyzing quality-of-life outcomes in cancer patients and spatial epidemiology of co-infections. Key contributions include the Validation of geospatial health indices Advancements in zero-inflated model testing Development of nonparametric scanning techniques Statistical frameworks for pediatric intervention evaluation He received a prestigious National Cancer Institute K01 award and has collaborated on federally-funded programs improving cardiovascular care in underserved populations. His work spans multiple domains including maternal-fetal medicine, environmental health, and global health equity. Methodological strengths include: Handling non-random missing data High-dimensional feature selection Weakly identifiable model sensitivity analysis Current research emphasizes translating statistical innovations into clinical practice through partnerships with healthcare systems and public health agencies.

Mar Rus-Calafellمشاهده پروفایل

پژوهشگر

• Mental Health
• Psychiatry
• Schizophrenia
• +۳ مورد دیگر

Mar Rus-Calafell is an active researcher at King's College London, specializing in the application of virtual reality (VR) technologies to mental health treatment. Her work focuses on psychosis, schizophrenia, and auditory hallucinations, particularly through innovative interventions like AVATAR Therapy. She contributes to advancing clinical psychology and psychiatry through randomized controlled trials and systematic reviews. Research Interests: Her expertise spans VR-assisted cognitive behavioral therapy (CBT), social functioning in psychosis, and the psychometric evaluation of therapeutic outcomes. She explores how multi-level VR paradigms can improve social performance and generalize therapeutic gains in clinical settings. Recent Work: Recent publications highlight VR's role in treating mental health conditions such as PTSD, eating disorders, and psychosis. She collaborates internationally on projects like AVATAR2, a multi-center trial evaluating AVATAR Therapy for distressing voices. Labs/Teams: Collaborates on the AVATAR2 project, a multidisciplinary effort involving clinical psychologists, software engineers, and psychiatrists to refine therapeutic VR applications.

• Biostatistics
• Health Informatics
• Mental Health
• +۶ مورد دیگر

Kirsty James is a Researcher in Biostatistics & Health Informatics at the Institute of Psychiatry, Psychology & Neuroscience, King's College London. With 330 citations and 27 research outputs including 26 articles and 1 letter, she specializes in biostatistics and health informatics with a focus on mental health research, particularly in autism, adolescent mental health, and cost-effectiveness analysis of interventions. Her research interests span Biostatistics, Health Informatics, Mental Health, Autism Research, Cost-Effectiveness Analysis, Randomized Controlled Trials, and Adolescent Mental Health. She applies sophisticated statistical methods to evaluate the clinical effectiveness and cost-effectiveness of mental health interventions, particularly those targeting children, adolescents, and caregivers. Her work often involves complex trial designs including cluster randomized controlled trials and economic evaluations. Analysis of her recent publications reveals a strong focus on evaluating interventions for autism spectrum disorder (particularly the REACH-ASD program for caregivers) and adolescent mental health (through the BESST trial). Her work consistently integrates rigorous biostatistical methods with health economic evaluation, demonstrating expertise in both clinical trial methodology and cost-effectiveness analysis across multiple healthcare domains. As Primary Investigator on the 'Emotional and Language recovery in Aphasia (ELA)' project funded by the NIHR National Institute For Health & Care Research (February 2025 to April 2027), she leads research developing novel interventions for people living with post-stroke aphasia. Her collaborative work extends across multiple significant projects including the REACH-ASD Trial, BESST trial, and CLEAR study on clozapine for early psychosis. Her research has been disseminated through high-impact journals including EClinicalMedicine, The Lancet Psychiatry, BMC Psychiatry, and Trials, with her work reaching diverse audiences through news outlets, social media platforms (X, Bluesky), and academic platforms like Mendeley.

Patrick Czorlichمشاهده پروفایل

مدرس ارشد

• Neurosurgery
• Traumatic Brain Injury
• Subarachnoid Hemorrhage
• +۵ مورد دیگر

Patrick Czorlich is a Senior physician and Medical Specialist in Neurosurgery at the University Medical Center Hamburg-Eppendorf (UKE), working within the Head and Neurocenter Department of Neurosurgery. He holds dual qualifications as a Prüfarzt (clinical trial physician) for both medicinal products and medical devices under German law. His clinical expertise spans neurosurgery with a specialized focus on neurosurgical intensive care. Dr. Czorlich's research interests are extensive within neurosurgical domains, with particular emphasis on traumatic brain injury, subarachnoid hemorrhage, neurocritical care, cerebrospinal fluid dynamics, and intracranial hemorrhage management. His work demonstrates a strong translational approach, bridging clinical practice with research to improve patient outcomes in complex neurosurgical cases. He has developed expertise in areas such as shunt dependency prediction, Terson Syndrome, and the management of complications following aneurysmal subarachnoid hemorrhage. Analysis of his recent publications (2023-2025) reveals a consistent research trajectory focused on improving outcomes in neurocritical care patients. His work spans clinical trials (including the FINISHER trial), predictive analytics using machine learning, management of complications following subarachnoid hemorrhage, and innovative approaches to neurosurgical interventions. Notably, his research often incorporates interdisciplinary collaboration, particularly with ophthalmology for Terson Syndrome studies and with critical care specialists for comprehensive patient management. His scientific contributions demonstrate expertise in both clinical neurosurgery and research methodology, with publications appearing in high-impact journals across neurosurgery, critical care, and related specialties. The consistent output of research and clinical studies indicates active engagement in advancing neurosurgical practice and patient care protocols.

David Aguilarمشاهده پروفایل

استاد

• Cardiology
• Cardiovascular Diseases
• Heart Failure
• +۳ مورد دیگر

David Aguilar, M.D., M.S.C.I., is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center and Section Chief of General and Noninvasive Cardiology within the Division of Cardiology. Certified by the American Board of Internal Medicine in cardiovascular diseases, he joined UT Southwestern in 2024 after serving as Professor of Medicine at LSU Health Science Center in New Orleans. His educational background includes: Bachelor of Science in Zoology (summa cum laude), Texas A&M University Doctor of Medicine (with honors), Baylor College of Medicine Internal Medicine Residency, Brigham and Women’s Hospital Cardiovascular Medicine Fellowship, Brigham and Women’s Hospital Master of Science in Clinical Investigation, Baylor Dr. Aguilar's research focuses on heart failure epidemiology, cardiovascular complications in diabetes, and environmental health impacts on cardiometabolic outcomes. He investigates toxic metal exposures in Hispanic populations and develops clinical guidelines for cardiovascular risk management. His work bridges clinical cardiology with population health research, emphasizing health disparities and preventive strategies. His extensive publication record (over 100 articles) shows strong emphasis on heart failure management guidelines, diabetes-cardiology interface, and environmental epidemiology. Recent work includes major AHA/ACC guideline documents and studies on metal exposures in Mexican American communities, reflecting his leadership in evidence-based cardiology and health disparities research. Professional honors include: Fellow of the American College of Cardiology Fellow of the American Heart Association Dr. Aguilar serves on editorial boards for American Heart Journal , Cardiovascular Drugs and Therapy , Circulation , and Diabetes Care , demonstrating significant scholarly influence. His national presentations and guideline committee roles indicate active mentorship and leadership in cardiovascular medicine, though specific grant details aren't provided in source materials. As Section Chief of General and Noninvasive Cardiology, he leads clinical and research teams focused on advancing heart failure care and cardiovascular risk management through evidence-based practice.

Paul S. Fishmanمشاهده پروفایل

استاد بالینی

• Neurodegenerative Diseases
• Parkinson’s Disease
• Alzheimer’s Disease
• +۸ مورد دیگر

Paul S. Fishman, M.D., Ph.D., is a Clinical Professor of Neurology and Adjunct Professor of Pharmacology at the University of Maryland School of Medicine. He is a dually trained neurologist and neuroscientist specializing in translating novel therapies for neurodegenerative disorders. His leadership includes founding the University of Maryland's Alzheimer’s clinical program, co-founding its Deep Brain Stimulation (DBS) initiative, and establishing the botulinum toxin treatment program for movement disorders. He previously served as Chief of Neurology at the VA Maryland Health Care System. Education & Training B.A. from Johns Hopkins University (1971) Ph.D. in Biology from Yale University (1975) M.D. from Johns Hopkins University School of Medicine (1978) Neurology Residency at Columbia-Presbyterian Medical Center Fellowship in Neurology/Anatomy at Columbia University Research Focus Dr. Fishman’s work spans: Neurodegenerative Therapies : Pioneering DBS and focused ultrasound (FUS) for Parkinson’s and essential tremor, including FDA-approved FUS thalamotomy. Drug Delivery Systems : Engineering tetanus toxin peptides for neuronal targeting and magnetic nanoparticle-enhanced stem cell delivery. Disease Mechanisms : Investigating mitochondrial dysfunction in Alzheimer’s models and botulinum toxin reversal strategies. Awards & Leadership Best Doctors in America (Honor) Past Chair: University IRB, School Promotions Committee, VA Parkinson’s Research Group Founding Member: Stem Cell Consortium, FUS Center of Excellence Active Grant Reviewer: NIH, VA, FDA, FUS Foundation

Michelle Newmanمشاهده پروفایل

استاد

• Anxiety Disorders
• Depression
• Emotion Regulation
• +۶ مورد دیگر

Michelle Newman is a Professor of Psychology at Pennsylvania State University's Department of Psychology within the College of Liberal Arts. She holds a Ph.D. from the State University of New York at Stony Brook (1992) and serves as the Principal Investigator of the Laboratory for Anxiety & Depression Research (LADR). Her research program spans adult clinical psychology with a focus on anxiety disorders and depression. Dr. Newman's research interests center on the nature and treatment of anxiety disorders and depression, with particular emphasis on the contrast avoidance model. Her work examines etiology and classification of disorders, individual predictors of psychotherapy outcomes, and the impact of brief digital interventions. She employs cutting-edge methodologies including ecological momentary assessment/intervention studies, machine learning approaches for emotion detection and therapy outcome prediction, and experimental paradigms examining underlying emotional processes. Analysis of her recent publications reveals a strong focus on transdiagnostic approaches to anxiety and depression, with particular emphasis on emotional contrast avoidance mechanisms. Her work bridges basic emotion science with clinical applications, frequently examining how momentary emotional processes relate to disorder maintenance and treatment outcomes. A significant portion of her recent work involves developing and testing digital interventions for anxiety disorders. Raymond Lombra Award for Distinction in the Social or Life Sciences (2019) Toy Caldwell-Colbert Award for Distinguished Educator in Clinical Psychology (2019) Dr. Newman has mentored numerous graduate students who have gone on to successful academic careers, including Nur Hani Zainal (now Assistant Professor at National University of Singapore), Hanjoo Kim (postdoctoral fellow at Michigan Medicine), Ki Eun Shin (assistant professor at Long Island University), and Lucas LaFreniere (assistant professor at Skidmore College). Her lab has secured substantial grant funding supporting research on digital mental health interventions, emotion regulation processes, and longitudinal studies of anxiety and depression. The Laboratory for Anxiety & Depression Research (LADR) conducts multiple concurrent projects examining basic emotional processes and developing innovative treatments for anxiety disorders. The lab employs diverse methodologies including ecological momentary assessment, randomized controlled trials of digital interventions, neurocognitive studies, and large-scale network analyses of psychopathology.

Jennifer Cocohobaمشاهده پروفایل

استاد

• HIV/AIDS
• Pharmacy Practice
• Medication Adherence
• +۳ مورد دیگر

Jennifer Cocohoba is a Professor in the Department of Clinical Pharmacy at the University of California San Francisco (UCSF) School of Pharmacy , where she holds the McKesson Professorship of Pharmaceutical Technology . As Vice Chair of Faculty Development , she mentors early-career faculty and promotes professional development opportunities. Her dual role as Clinical Pharmacist at the Women’s HIV Program focuses on optimizing antiretroviral therapy, adherence strategies, and opioid stewardship. Education: PharmD (2001, UCSF) MAS in Clinical Research (2008, UCSF) Certificate in Implementation Sciences (2012, UCSF) Certificate in Geographic Information Sciences (2013, Cal Poly Pomona) HIV Expert certification (2008, American Academy of HIV Medicine) Her research spans HIV treatment and prevention , with emphasis on medication adherence , health disparities , pharmacoepidemiology , and implementation science . She investigates sex-related disparities in HIV care, Filipina-American health behaviors, and pharmacy-based interventions for chronic disease management. Recent studies focus on integrase inhibitor-related weight gain , long-acting injectable therapies , and telemedicine for alcohol use disorders . Scientific recognition includes: Fellow of the California Society of Health-System Pharmacists (2012) Endowed chair appointments at UCSF (2022) Honors from the UCSF Academy of Medical Educators (2021) She actively contributes to pharmacy education reform and policy analysis , including work on expanding pharmacist prescribing authority for HIV pre-exposure prophylaxis (PrEP) . Her community engagement with Mabuhay Health Center and research in pharmacist-patient communication reflect her commitment to equitable healthcare delivery.

Karin Sundströmمشاهده پروفایل

پژوهشگر

• Cancer Epidemiology
• Human Papillomavirus (HPV)
• Cervical Cancer Screening
• +۶ مورد دیگر

Karin Sundström is a Principal Researcher at the Karolinska Institute , affiliated with the Department of Clinical Science, Intervention and Technology and leading the Human papillomavirus which causes cervical cancer – Research Group . She serves as a research group leader and cancer epidemiologist with extensive experience in molecular epidemiology and biobank infrastructure utilization. MD-PhD trained medical scientist Active in eHealth and big data applications Principal investigator for multiple international collaborations Research Interests: HPV-associated cancer elimination Biomarker development for female cancers Register-based cervical screening optimization Next-generation sequencing applications Machine learning in medical records analysis Epidemiology of herpes zoster Scientific Contributions: With over 20 publications in 2023-2024 alone, her work spans HPV vaccination effectiveness, cervical screening algorithms, and cancer risk stratification using epigenetic markers. Her MERMAID III initiative focuses on ovarian cancer prevention through biomarker research. Selected Awards: Swedish Cancer Society Project Grant (2022-2023) CIMED Junior Grant (2020-2022) Jonas Söderquist Award for Virology Research (2016) Academic Leadership: Supervises multiple doctoral and postdoctoral researchers including Dr. Jiangrong Wang, and serves as study director for KI's Diagnostic Cytology program. Previously coordinated the Nordic Information for Action eScience Center (NIASC) eHealth projects.

• Rehabilitation Science
• Neurorehabilitation
• Balance Disorders
• +۷ مورد دیگر

Dr. Kelly P. Westlake serves as Professor in the Department of Physical Therapy and Rehabilitation Science at the University of Maryland School of Medicine, with secondary appointments in Diagnostic Radiology Nuclear Medicine and Neurology. As Director of the PhD and DPT/PhD program in Physical Rehabilitation Science, she leads advanced training initiatives while maintaining thirty years of clinical and research expertise focused on neurological disorders and age-related mobility decline. Her educational foundation includes a Physical Therapy degree from McGill University, M.Sc. and Ph.D. degrees in Rehabilitation Sciences from Queen's University, followed by postdoctoral training at Stanford University/Palo Alto VA (CIHR Clinical Research fellowship) and University of California, San Francisco (American Heart Association Fellowship). This trajectory established her dual expertise in clinical neurorehabilitation and advanced neuroscience methodology. Dr. Westlake's research program investigates sensorimotor-cognitive mechanisms underlying movement impairments in stroke, Parkinson's disease, and mild cognitive impairment through an integrative approach combining biomechanics (kinematics/kinetics), neuroimaging (fMRI/EEG/MEG), and psychophysiological assessments (HRV/GSC). Her distinctive work explores sleep-based motor learning consolidation via targeted memory reactivation and cognitive-motor interactions in reactive fall recovery, driving development of task-oriented robotic rehabilitation devices for clinical translation. Recent publications reveal strong trends toward home-based and self-managed rehabilitation solutions for stroke recovery, with growing emphasis on cognitive-motor interactions in aging populations and biomechanical analysis of perturbation responses for fall prevention. These studies consistently prioritize patient-centered, evidence-based interventions leveraging technological innovation to enhance accessibility and efficacy. Her scientific recognition includes: CIHR Clinical Research fellowship American Heart Association Fellowship Dr. Westlake currently leads $10+ million in grant funding including a 2025-2026 Maryland Industrial Partnerships Grant for FES treatment of shoulder adhesive capsulitis and multiple NIH awards (NIDILRR, NIA, NINDS) focused on stroke rehabilitation, fall prevention in older adults, and neuromotor training. She mentors PhD candidates and postdoctoral fellows through the Physical Rehabilitation Science PhD Program and UMANRRT fellowship, while developing clinical practice guidelines as Leader of the Balance and Falls in Neurological Conditions group for the APTA Academy of Neurologic Rehabilitation. The Neuromechanisms of Movement and Learning (NeuMo) Laboratory, directed by Dr. Westlake, features state-of-the-art capabilities including fMRI/EEG/MEG neuromonitoring, Vicon kinematics, Bertek force platforms, ActiveStep balance perturbation system, custom Balance boardwalk (patent pending), and Kinereach virtual reality systems. The lab maintains active collaborations with the UM Sleep Lab and UM Rehab for clinical-home integration studies, supported by academic-industry partnerships advancing rehabilitation technology development.

Sabrina Cavalloمشاهده پروفایل

دانشیار

• Physical Medicine & Rehabilitation
• Pediatrics
• Developmental Pediatrics
• +۵ مورد دیگر

Sabrina Cavallo is an Associate Professor at the Faculty of Medicine - School of Rehabilitation, Department of Occupational Therapy, University of Montreal. She specializes in promoting physical activity and social participation for children and adolescents with chronic diseases like juvenile idiopathic arthritis, focusing on knowledge translation and healthcare transition to adulthood. Education: BSc in Occupational Therapy, McGill University (2003) PhD in Public Health (Epidemiology), University of Montreal (2016) Postdoctoral Fellowship in Knowledge Translation, University of Ottawa Research Interests: Physical activity promotion for youth with chronic illnesses Social participation determinants in physically impaired adolescents Knowledge transfer in pediatric rehabilitation Transition from pediatric to adult healthcare Impact of ICT/social media on rehabilitation Developmental pediatrics for disability populations Recent Article Trends: Her 15 most recent publications focus on structured physical activity interventions for juvenile arthritis, evidence-based clinical guidelines for osteoarthritis management, knowledge translation strategies, and adaptive sports programs for chronic pain. Keywords include pediatric rehabilitation, digital health, chronic disease management, and social determinants of youth development. Research Funding: She has secured grants from Canadian Institutes of Health Research (CIHR), Fonds de recherche du Québec – Santé (FRQS), CMA Foundation, and Office des personnes handicapées du Québec for projects related to virtual care ethics, patient engagement, and adaptive sports interventions. Teaching & Supervision: Sabrina teaches advanced occupational therapy courses (ERT-1401, ERT-6073) and supervises graduate research, including Zeinab Ahmadian Sangkar's 2024 Master's thesis on social media and physical activity in juvenile arthritis. Research Affiliations: She operates at the Interdisciplinary Research Center in Rehabilitation of Metropolitan Montreal (CRIR) and the Sainte-Justine University Hospital Research Center, collaborating with multidisciplinary teams across Canada.

Julia L. Finkelsteinمشاهده پروفایل

دانشیار

• Epidemiology and Nutrition
• One-carbon metabolism
• Maternal and child health
• +۳ مورد دیگر

Julia L. Finkelstein, MS, MPH, ScD, is Associate Professor of Epidemiology and Nutrition in the Division of Nutritional Sciences at Cornell University’s College of Human Ecology and concurrently Associate Professor of Epidemiology in the Division of Epidemiology, Department of Population Health Sciences at Weill Cornell Medical College. She is the Follett Sesquicentennial Faculty Fellow , Director of the Maternal and Child Nutrition Program , and co-Director of the Joan Klein Jacobs Center for Precision Nutrition and Health , the Cochrane Center , and the WHO Collaborating Centre at Cornell. She also holds an adjunct Associate Professor appointment at St. John’s Research Institute, Bengaluru, India . Education Bachelor of Science – McGill University, Montréal, Canada Master of Public Health – Brown University, USA Master of Science – Harvard University (Epidemiology and Nutrition) Doctor of Science – Harvard University (Epidemiology and Nutrition) Research Focus Dr. Finkelstein is an epidemiologist whose laboratory centers on one-carbon metabolism and its role in women’s health across the lifespan—from preconception through pregnancy and postpartum. She designs and conducts large-scale randomized clinical trials, cohort studies, and surveillance programs in resource-limited settings in India, Sub-Saharan Africa, Latin America, and the United States . Her work integrates precision nutrition, mobile point-of-care diagnostics, and AI-driven analytics to improve maternal, neonatal, and child health outcomes. Scientific Awards & Honors NIH Technology Accelerator Challenge Prize – Innovative Global Health Diagnostics SUNY Chancellor Award for Scholarship & Creative Activities International Life Sciences Institute (ILSI) Award – Leadership in Nutrition Chair, Federation of American Societies for Experimental Biology (FASEB) One-Carbon Metabolism Research Interest Group (recently elected) Grants & Leadership Roles Dr. Finkelstein is Program Director of an NIH-funded training program on maternal and child nutrition and leads the Clinical Core of the NIH-funded PORTENT Center (Point-of-Care Diagnostics for Nutrition, Infection, and Cancer) within the NIH POCTRN network. She is a Global Public Voices Fellow (2021–22) through Cornell’s Einaudi Center, advocating for social and health equity in vulnerable populations. Laboratory & Teams The Finkelstein Laboratory at Cornell focuses on mechanistic and translational research in one-carbon metabolism, leveraging state-of-the-art biomarker assays, body-composition analyses, and microbiome profiling to develop and test precision nutrition interventions for women and children globally.